Opportunity Information: Apply for RFA DA 14 008
Apply for RFA DA 14 008
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "FY14 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on May 30, 2013 and posted on May 30, 2013.
- Applicants must submit their applications by Nov 6, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: For profit organizations other than small businesses State governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Small businesses Private institutions of higher education Independent school districts County governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public housing authorities/Indian housing authorities.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The FY14 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) is a National Institutes of Health (NIH) funding opportunity from the National Institute on Drug Abuse (NIDA) designed to back individual scientists whose work is unusually creative and likely to reshape the field. The central goal is to support high impact, highly innovative HIV/AIDS research that can open genuinely new directions and create fresh paths toward prevention and treatment, specifically in ways that matter for people who use drugs or populations affected by drug abuse. In this program, "avant garde" is not just a label for incremental novelty; it signals work that is intentionally transformative, taking risks on ideas and approaches that could change assumptions, methods, or trajectories in HIV/AIDS research rather than simply extending what is already being done.
A key expectation is that the proposed research should be substantially different from lines of work already being pursued, whether by the applicant or by others in the field. That emphasis on distinctiveness means the application should read as a departure from standard playbooks and routine next steps. Consistent with priorities described in the FY14 Trans-NIH Research Budget Justification, the program is especially interested in innovative basic research that could lead to practical downstream impacts, such as improved preventive interventions or therapies. NIDA highlights several example directions, including creative new strategies to prevent HIV transmission, novel approaches to improve disease outcomes for people living with HIV, and bold concepts aimed at eradicating HIV or meaningfully improving quality of life. While the language points to basic research, the through-line is clear: the science should be foundational but oriented toward breakthroughs that could eventually translate into better prevention, treatment, and long-term outcomes in real-world settings affected by drug use.
Administratively, this opportunity is identified as Funding Opportunity Number RFA-DA-14-008, with the title "FY14 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1)." It is a discretionary grant mechanism under the health and education activity areas, and it falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The announcement was posted on May 30, 2013, with an original and current closing date of November 6, 2013, and an archive date of December 7, 2013. NIDA listed an estimated total program funding amount of $2,000,000, with an award ceiling of $500,000. The opportunity does not require cost sharing or matching, which reduces barriers for applicants who may not have institutional resources to contribute matching funds.
Eligibility is broad and intentionally inclusive, spanning many organization types. Eligible applicants include for-profit organizations (other than small businesses) and small businesses, nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those particular nonprofit categories as specified), public and private institutions of higher education, and a wide range of government entities such as state governments, county governments, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. Tribal eligibility is also extensive, covering federally recognized Native American tribal governments as well as tribal organizations and tribal governments that are not federally recognized. The eligibility language further includes faith-based or community-based organizations, regional organizations, and eligible federal agencies.
The announcement explicitly welcomes applications from institutions serving historically underrepresented communities, including Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-Serving Institutions, and Asian American and Native American Pacific Islander-Serving Institutions (AANAPISIs). International participation is also permitted: non-U.S. entities (foreign organizations and foreign institutions) are eligible to apply, non-U.S. components of U.S. organizations may apply, and foreign components are allowed as defined under NIH Grants Policy. That openness signals an intent to draw the best high-risk, high-reward ideas regardless of geography, as long as they align with NIDA's HIV/AIDS priorities connected to drug abuse and addiction contexts.
For applicants seeking more detail, the full announcement was linked through NIH at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-14-008.html. For technical access issues or problems reaching the funding announcement, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the FY14 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1)?
It is a National Institutes of Health (NIH) funding opportunity run by the National Institute on Drug Abuse (NIDA) to support individual scientists proposing unusually creative, high-impact HIV/AIDS research. The program is meant to back work that is genuinely transformative and could reshape assumptions, methods, or trajectories in HIV/AIDS research.
What is the main goal of this funding opportunity?
The central goal is to support highly innovative HIV/AIDS research that opens new directions and creates fresh paths toward prevention and treatment, especially in ways that matter for people who use drugs or populations affected by drug abuse.
What does "avant garde" mean in the context of this award?
In this program, "avant garde" is not about incremental novelty. It signals intentionally transformative research that takes risks on ideas and approaches that could change how HIV/AIDS research is pursued, rather than simply extending existing work.
What kind of research is NIDA looking for?
NIDA is looking for high-impact, highly innovative HIV/AIDS research, with particular interest in innovative basic research that could eventually lead to practical downstream impacts such as improved preventive interventions or therapies. The proposal should be oriented toward breakthroughs that could translate into better prevention, treatment, and long-term outcomes in settings affected by drug use.
Does the proposed research need to be different from an applicant's current work?
Yes. A key expectation is that the proposed research should be substantially different from lines of work already being pursued, whether by the applicant or by others in the field. The application should read as a departure from standard approaches and routine next steps.
Are there example topic areas that NIDA highlights?
Yes. NIDA highlights examples such as creative new strategies to prevent HIV transmission, novel approaches to improve disease outcomes for people living with HIV, and bold concepts aimed at eradicating HIV or meaningfully improving quality of life.
How is this opportunity identified (funding opportunity number and title)?
The Funding Opportunity Number is RFA-DA-14-008 and the title is "FY14 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1)."
What agency is offering this grant?
This is an NIH funding opportunity offered by the National Institute on Drug Abuse (NIDA).
What is the CFDA number for this program?
The CFDA number listed is 93.279 (Drug Abuse and Addiction Research Programs).
What are the relevant activity areas?
The opportunity is described as a discretionary grant mechanism under the health and education activity areas.
When was the opportunity posted, and what are the key dates?
The announcement was posted on May 30, 2013. The original and current closing date was November 6, 2013, and the archive date was December 7, 2013.
How much total funding was estimated for the program?
NIDA listed an estimated total program funding amount of $2,000,000.
What is the award ceiling?
The award ceiling listed is $500,000.
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching.
Who is eligible to apply?
Eligibility is broad and includes many organization types, including for-profit organizations (other than small businesses) and small businesses; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those particular nonprofit categories as specified); public and private institutions of higher education; and a wide range of government entities.
Which government entities are eligible?
Eligible government entities include state governments, county governments, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities.
Are tribal governments and tribal organizations eligible?
Yes. Eligibility includes federally recognized Native American tribal governments, tribal governments that are not federally recognized, and tribal organizations.
Are faith-based or community-based organizations eligible?
Yes. The eligibility language includes faith-based or community-based organizations, as well as regional organizations.
Are federal agencies eligible to apply?
Yes. The eligibility list includes eligible federal agencies.
Does the announcement encourage applications from institutions serving historically underrepresented communities?
Yes. The announcement explicitly welcomes applications from Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-Serving Institutions, and Asian American and Native American Pacific Islander-Serving Institutions (AANAPISIs).
Are foreign (non-U.S.) organizations allowed to apply?
Yes. Non-U.S. entities (foreign organizations and foreign institutions) are eligible to apply.
Can non-U.S. components of U.S. organizations apply?
Yes. Non-U.S. components of U.S. organizations may apply.
Are foreign components allowed under this opportunity?
Yes. Foreign components are allowed as defined under NIH Grants Policy.
Where can applicants find the full funding announcement?
The full announcement is available through NIH at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-14-008.html.
Who should be contacted for technical access issues related to the announcement?
For technical access issues or problems reaching the funding announcement, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Services Research for Autism Spectrum Disorder across the Lifespan (ServASD) Pilot Research on Services for Transition Age Youth (R34)
Previous opportunity: Reissue PHS 2013 02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR R41/R42)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 14 008
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 14 008) also looked into and applied for these:
| Funding Opportunity |
|---|
| Integrating Substance Abuse Prevention and Treatment within HIV/AIDS Service Delivery Settings (R01) Apply for RFA DA 14 011 Funding Number: RFA DA 14 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| HIV/AIDS and Substance Use among Black/African American Women and Young MSM (R01) Apply for RFA DA 14 010 Funding Number: RFA DA 14 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV/AIDS and Substance Use Among the Homeless and Unstably Housed (R01) Apply for RFA DA 14 009 Funding Number: RFA DA 14 009 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Comorbid HIV, Chronic Pain, and Substance Use among Older Adults (R21) Apply for RFA DA 14 012 Funding Number: RFA DA 14 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research to Characterize and Reduce Stigma to Improve Health (R21) Apply for PA 13 246 Funding Number: PA 13 246 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research to Characterize and Reduce Stigma to Improve Health (R03) Apply for PA 13 247 Funding Number: PA 13 247 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Research to Characterize and Reduce Stigma to Improve Health (R01) Apply for PA 13 248 Funding Number: PA 13 248 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Adult Brain Tumor Consortium (ABTC) (UM1) Apply for RFA CA 13 501 Funding Number: RFA CA 13 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Limited Competition Pediatric Brain Tumor Consortium (UM1) Apply for RFA CA 13 502 Funding Number: RFA CA 13 502 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,590,000 |
| Clinical Trials and Interventional Studies of Non Pharmacological Approaches to Managing Pain and Co Morbid Conditions in U.S. Military Personnel, Veterans, and their Families (R01) Apply for RFA AT 14 003 Funding Number: RFA AT 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Pilot and Feasibility Studies of Non Pharmacological Approaches to Managing Pain and Co Morbid Conditions in U.S. Military Personnel, Veterans, and their Families (R34) Apply for RFA AT 14 004 Funding Number: RFA AT 14 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Health Services and Observational Studies of Non Pharmacological Approaches to Managing Pain and Co Morbid Conditions in U.S. Military Personnel, Veterans, and their Families (R01) Apply for RFA AT 14 005 Funding Number: RFA AT 14 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Program Project Grant Applications (P01) Apply for PAR 13 259 Funding Number: PAR 13 259 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Synergizing Omic and Symptom Science (R15) Apply for PA 13 265 Funding Number: PA 13 265 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Synergizing Omic and Symptom Science (R01) Apply for PA 13 264 Funding Number: PA 13 264 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Grand Opportunity in Medications Development for Substance Use Disorders (U01) Apply for PAR 13 270 Funding Number: PAR 13 270 Agency: National Institutes of Health Category: Education Health Funding Amount: $5,000,000 |
| Revision Applications to Promote Collaborative Research on Addiction at NIH (CRAN) Comorbidity Related Research (R01) Apply for RFA DA 14 014 Funding Number: RFA DA 14 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Administrative Supplements to Promote Collaborative Research on Addiction at NIH (CRAN) Comorbidity Related Research (Admin Supp) Apply for PA 13 275 Funding Number: PA 13 275 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Abuse Resistant and Abuse Deterrent Formulations and Devices to Avoid the Abuse, Misuse and Diversion of Prescription Opioids by Patients (SBIR)(R43/R44) Apply for RFA DA 14 013 Funding Number: RFA DA 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PAR 13 282 Funding Number: PAR 13 282 Agency: National Institutes of Health Category: Education Health Funding Amount: $175,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 14 008", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.